You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Clinical and economic outcomes among injection-naïve patients with type 2 diabetes initiating dulaglutide compared with basal insulin in a US real-world setting: the DISPEL Study

Citation Tools

Article menu

Download PDFPDF

Emerging technology, pharmacology and Therapetics
Original research
Clinical and economic outcomes among injection-naïve patients with type 2 diabetes initiating dulaglutide compared with basal insulin in a US real-world setting: the DISPEL Study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Mody R, Huang Q, Yu M, et al
Clinical and economic outcomes among injection-naïve patients with type 2 diabetes initiating dulaglutide compared with basal insulin in a US real-world setting: the DISPEL Study
BMJ Open Diabetes Research and Care 2019;7:e000884. doi: 10.1136/bmjdrc-2019-000884